| abstract |
ThenInvention includes a system for endothelial cell-specific targetingnbased on recombinant, replication-deficient pseudotype viruses,nthe at least one specific protein of the host, preferablynVascular Endothelial Growth Factor (VEGF), stable or unstablenas a receptor binding site on the shell wear and thus anEndothelial cell tropism, which they use for targetedncompetent in tumor and gene therapy. |